文献速递血栓与止血

肝素激活促凝血血小板试验:一种基于流式细胞术的肝素诱导性血小板减少症功能检测

Heparin-activated procoagulant platelet assay: a flow cytometry-based functional test for heparin-induced thrombocytopenia.
PubMed 文献 · J Thromb Haemost · 2023-10-13

该研究评估基于流式细胞术的肝素激活促凝血血小板(HAPP)试验在肝素诱导性血小板减少症(HIT)实验室诊断中的准确性。以前瞻性队列(n=202)连续送检标本验证,以肝素诱导血小板活化(HIPA)试验为参考标准,HAPP试验敏感性93.3%、特异性96.8%。作者认为HAPP试验有望成为简单可靠的功能性检测,但需在更大 cohort 中进一步研究确认。

要点

  • HAPP试验阳性需同时满足3条标准:0.2 IU/mL肝素孵育后促凝血血小板≥10.3%、较缓冲液倍数升高≥1.5、100 IU/mL肝素抑制≥50%。
  • 前瞻性验证队列n=202,其中HIPA+ 15份、HIPA- 187份,HAPP阳性20份。
  • 采用优化cut-off后,HAPP试验敏感性93.3%、特异性96.8%。

核心结论

  • HAPP试验有望作为HIT的简单可靠的功能性检测,但需在更大 cohort 中进一步研究确认结果。

研究设计与样本

  • 前瞻性队列验证研究,连续纳入送检至本实验室进行HIT血清学诊断的标本n=202,以HIPA试验为参考标准。
  • 以流式细胞术检测健康供者富血小板血浆与患者血清孵育后(含或不含肝素)的促凝血血小板(PCP),PCP定义为磷脂酰丝氨酸和CD62-P表达。

主要发现

  • HIT阳性血清在0.2 IU/mL肝素存在下诱导PCP,该作用可被100 IU/mL肝素抑制。
  • 验证队列中HIPA+ 15份、HIPA- 187份,HAPP阳性20份。
  • 采用优化cut-off,HAPP试验敏感性93.3%、特异性96.8%。

关键数值与推荐

  • HAPP试验阳性标准1:0.2 IU/mL肝素孵育后PCP百分比≥10.3%。
  • HAPP试验阳性标准2:0.2 IU/mL肝素存在下PCP较缓冲液的倍数升高≥1.5。
  • HAPP试验阳性标准3:100 IU/mL肝素导致PCP抑制≥50%。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 作者指出需在更大 cohort 中进一步研究以确认结果。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Functional platelet activation assays are required for the diagnosis of heparin-induced thrombocytopenia (HIT). Due to their sophisticated methodology, they are only available in reference centers. OBJECTIVES: To evaluate the diagnostic accuracy of the flow cytometry-based heparin-activated procoagulant platelet (HAPP) assay in the laboratory diagnosis of HIT. METHODS: Procoagulant platelets (PCP), defined by the expression of phosphatidylserine and CD62-P, were evaluated by flow cytometry in platelet-rich plasma from healthy donors after incubation with patient sera in the absence and presence of heparin. A sample was considered positive in HAPP assay, if the following 3 criteria were met: 1) the percentage of PCPs was ≥10.3% after incubation with 0.2 IU/mL heparin, 2) the fold increase in presence of 0.2 IU/mL heparin compared with buffer was ≥1.5, and 3) 100 IU/mL of heparin resulted in ≥50% inhibition of PCP. HAPP assay was validated in a prospective cohort (n = 202) of consecutive specimens submitted to our laboratory for serologic diagnosis of HIT. Heparin-induced platelet activation (HIPA) assay was used as the reference standard. RESULTS: HIT-positive sera induced PCPs in the presence of 0.2 IU/mL heparin, which was inhibited with 100 IU/mL of heparin. In the prospective validation cohort, there were 15 HIPA+ and 187 HIPA- sera. HAPP was positive in 20 samples in this cohort. Using optimized cut-offs, HAPP assay had a sensitivity of 93.3% and specificity of 96.8%. CONCLUSION: HAPP assay is promising as a simple and reliable functional assay for HIT; however, further studies are needed to confirm our results in larger cohorts.

来源:J Thromb Haemost,查看原文。版权归原作者所有。

引用

  1. Pelzl L, Uzun G, Marini I, et al. Heparin-activated procoagulant platelet assay: a flow cytometry-based functional test for heparin-induced thrombocytopenia. J Thromb Haemost. 2023. PMID: 37838242. doi:10.1016/j.jtha.2023.10.003

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。